1158786-59-4 Usage
Uses
Used in Pharmaceutical Industry:
2-Amino-6-bromo-4-methoxypyridine is utilized as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and functional groups contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Amino-6-bromo-4-methoxypyridine serves as an intermediate for the production of agrochemicals. Its chemical properties allow for the creation of compounds that can be used in pest control and crop protection, enhancing agricultural productivity and sustainability.
Used in Organic Compounds Synthesis:
2-Amino-6-bromo-4-methoxypyridine is also employed as an intermediate in the synthesis of other organic compounds. Its reactivity and functional groups enable the production of a wide range of chemical products for various applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1158786-59-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,8,7,8 and 6 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1158786-59:
(9*1)+(8*1)+(7*5)+(6*8)+(5*7)+(4*8)+(3*6)+(2*5)+(1*9)=204
204 % 10 = 4
So 1158786-59-4 is a valid CAS Registry Number.
1158786-59-4Relevant academic research and scientific papers
SUBSTITUTED IMIDAZO [1, 2-A] PYRIDINE AND [1, 2, 4] TRIAZOLO [1, 5-A] PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
-
Paragraph 144; 155; 158-159, (2020/05/12)
Provided are certain RET inhibitors, pharmaceutical compositions thereof, and methods of use thereof.
PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS
-
Page/Page column 71, (2014/01/17)
The present invention provides a compound of formula I: (I) a method for manufacturing the compounds of the invention, and its therapeutic uses as complement alternative inhibitors for the treatment of ocular diseases. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
NEW PYRIDINES AS FBPASE INHIBITORS FOR TREATMENT OF DIABETES
-
Page/Page column 25; 35, (2009/06/27)
Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof wherein the residues have the significance given in claim 1 and which can be used in the form of pharmaceutical compositions.
